LifeMD, Inc.
For the period ended Dec 31, 2025. Filed Mar 10, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 10, 2026
LFMD$2.10-11.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
| Year Ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Telehealth revenue, net | $194,055,198 | $154,824,075 |
| Cost of telehealth revenue | 27,714,808 | 21,440,799 |
| Gross profit | 166,340,390 | 133,383,276 |
| Expenses | ||
| Selling and marketing expenses | 86,074,473 | 70,102,961 |
| General and administrative expenses | 57,937,023 | 57,947,932 |
| Customer service expenses | 11,579,636 | 10,217,654 |
| Other operating expenses | 11,073,155 | 8,659,712 |
| Development costs | 7,345,797 | 6,857,005 |
| Total expenses | 174,010,084 | 153,785,264 |
| Operating loss from continuing operations | (7,669,694) | (20,401,988) |
| Interest expense, net | (1,360,967) | (2,175,405) |
| Loss on debt extinguishment | (1,155,851) | - |
| Loss from continuing operations before income taxes | (10,186,512) | (22,577,393) |
| Income tax provision | (45,721) | (598,000) |
| Net loss from continuing operations | (10,232,233) | (23,175,393) |
| Net income from discontinued operations | 25,852,024 | 2,315,252 |
| Net income (loss) | 15,619,791 | (20,860,141) |
| Net income attributable to non-controlling interest of discontinued operations | 1,265,685 | 548,875 |
| Net income (loss) attributable to LifeMD, Inc. | 14,354,106 | (21,409,016) |
| Preferred stock dividends | (3,106,250) | (3,106,250) |
| Net income (loss) attributable to LifeMD, Inc. common stockholders | $11,247,856 | $(24,515,266) |
| Basic earnings (loss) per share attributable to LifeMD, Inc. common stockholders: | ||
| Continuing operations | $(0.30) | $(0.64) |
| Discontinued operations | 0.54 | 0.04 |
| Basic earnings (loss) per share | $0.25 | $(0.60) |
| Diluted earnings (loss) per share attributable to LifeMD, Inc. common stockholders: | ||
| Continuing operations | $(0.30) | $(0.64) |
| Discontinued operations | 0.54 | 0.04 |
| Diluted earnings (loss) per share | $0.25 | $(0.60) |
| Weighted average number of common shares outstanding: | ||
| Basic | 45,129,617 | 41,196,292 |
| Diluted | 45,129,617 | 41,196,292 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.